SCHEMBL12388657

SCHEMBL12388657

CCC(C)(C)[C@@H](C)c1cc(CO)ccc1-c1cc(OC)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12388656 1.00 FFAR1 (0.43) FFAR1
SCHEMBL2316137 0.90 FFAR1 (0.45) FFAR1
SCHEMBL12192258 0.90 FFAR1 (0.45) FFAR1
SCHEMBL2315397 0.90 FFAR1 (0.45) FFAR1
SCHEMBL2318347 0.89 FFAR1 (0.49) FFAR1
SCHEMBL2312981 0.89 FFAR1 (0.49) FFAR1
SCHEMBL12388667 0.89 FFAR1 (0.40) FFAR1
SCHEMBL12388664 0.89 FFAR1 (0.40) FFAR1
SCHEMBL12192400 0.82 FFAR1 (0.54) FFAR1
SCHEMBL12192219 0.82 FFAR1 (0.43) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190330-A1 SPIROCYCLIC GPR40 MODULATORS AMGEN INC. (US) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190330-A1 SPIROCYCLIC GPR40 MODULATORS GPR119, GPR55, GPR65 FFAR1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.